首页> 外文期刊>Der Pharmacia Lettre >New validated UV spectrophotometric method for the estimation of rebamipide and tramadol in bulk and dosage forms
【24h】

New validated UV spectrophotometric method for the estimation of rebamipide and tramadol in bulk and dosage forms

机译:经验证的新的紫外分光光度法可估算散装和剂型中的瑞巴派特和曲马多

获取原文
           

摘要

New UV spectrophotometric (UV method) for the quantitative estimation of rebamipide, a potent antiulcer agent and tramadol, a centrally acting analgesic in pure form and in solid dosage forms was developed in the present study. The linear regression equations for rebamipide was Abs=0.09944Conc. (in μg/mL)+0.022 and tramadol was Abs=0.0059Conc. (in μg/mL)+0.003 measured at 228 nm and 271 nm respectively. The detection limit for rebamipide and tramadol was found to be 0.27μg/mL and 0.24μg/mL. The results of analysis were treated statistically, as per ICH guidelines for validation of analytical procedures, and by recovery studies.
机译:本研究开发了一种新的紫外分光光度法(UV方法),用于定量评估瑞巴派特,一种有效的抗溃疡剂和曲马多(一种纯净形式和固体剂型的中枢镇痛药)。瑞巴派特的线性回归方程为Abs = 0.09944Conc。 (以μg/ mL为单位)+0.022,曲马多的Abs = 0.0059Conc。 (以μg/ mL为单位)+0.003分别在228 nm和271 nm下测得。瑞巴派特和曲马多的检出限分别为0.27μg/ mL和0.24μg/ mL。根据ICH确认分析程序的指导原则并通过回收率研究,对分析结果进行统计学处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号